CNS Pharmaceuticals Inc. (CNSP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CNS Pharmaceuticals Inc.

    NASDAQ: CNSP · Real-Time Price · USD
    8.91
    0.26 (3.01%)
    At close: Sep 26, 2025, 3:59 PM
    8.68
    -2.58%
    After-hours: Sep 26, 2025, 07:49 PM EDT

    CNS Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 3.31K 4.13K 11.76K 13.07K
    Gross Profit
    		 -3.31K -4.13K -11.76K -13.07K
    Operating Income
    		 -14.9M -18.87M -15.27M -14.49M
    Interest Income
    		 60.26K 27.69K 7.03 9.29
    Pretax Income
    		 -14.86M -18.85M -15.27M -14.5M
    Net Income
    		 -14.86M -18.85M -15.27M -14.5M
    Selling & General & Admin
    		 5.61M 4.77M 5.97M 4.68M
    Research & Development
    		 9.29M 14.1M 9.3M 9.35M
    Other Expenses
    		 n/a -4.13K n/a 458.62K
    Operating Expenses
    		 14.9M 18.86M 15.27M 14.49M
    Interest Expense
    		 16.12K 13.8K 7.03K 9.29K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -14.9M 18.87M 15.27M 14.03M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 317.26K 6.22M 2.26M 1.41M
    Shares Outstanding (Diluted)
    		 317.26K 6.22M 2.26M 1.46M
    EPS (Basic)
    		 -38.87 -60 -134.64 -6.36
    EPS (Diluted)
    		 -38.87 -60 -134.64 -6.36
    EBITDA
    		 -14.9M -18.86M -15.26M -14.47M
    EBIT
    		 -14.87M -18.87M -15.27M -14.49M
    Depreciation & Amortization
    		 3.31K 4.13K 11.76K 13.07K

    Add to Watchlist